NasdaqGM - Delayed Quote USD
Acrivon Therapeutics, Inc. (ACRV)
1.2000
-0.0700
(-5.51%)
At close: June 13 at 4:00:01 PM EDT
1.2000
0.00
(0.00%)
After hours: June 13 at 5:54:40 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.58 | -0.58 | -2.24 | -2.37 |
| Low Estimate | -0.71 | -0.76 | -2.9 | -3.5 |
| High Estimate | -0.47 | -0.44 | -1.73 | -1.72 |
| Year Ago EPS | -0.52 | -0.59 | -2.38 | -2.24 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | -- | -- | 129.33k | 1.47M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 1.16M | 10.5M |
| Year Ago Sales | -- | -- | -- | 129.33k |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 1,034.39% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.57 | -0.59 | -0.7 | -0.65 |
| EPS Actual | -0.52 | -0.59 | -0.54 | -0.51 |
| Difference | 0.05 | 0 | 0.16 | 0.14 |
| Surprise % | 8.77% | 0.24% | 23.30% | 21.05% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.58 | -0.58 | -2.24 | -2.37 |
| 7 Days Ago | -0.65 | -0.61 | -2.54 | -2.38 |
| 30 Days Ago | -0.64 | -0.67 | -2.64 | -2.5 |
| 60 Days Ago | -0.75 | -0.79 | -2.96 | -2.79 |
| 90 Days Ago | -0.8 | -0.88 | -2.91 | -2.79 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | -- | 2 | 2 |
| Up Last 30 Days | 1 | -- | 3 | 2 |
| Down Last 7 Days | -- | 2 | 1 | -- |
| Down Last 30 Days | -- | 1 | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACRV | -12.18% | 1.69% | 6.02% | -5.89% |
| S&P 500 | 13.13% | 2.43% | 7.54% | 14.06% |
Upgrades & Downgrades
| Downgrade | Jones Trading: Buy to Hold | 5/16/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/15/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/26/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/26/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/26/2025 |
Related Tickers
ANTX AN2 Therapeutics, Inc.
1.0700
-5.31%
IKNA Ikena Oncology, Inc.
1.3500
-1.46%
ACRS Aclaris Therapeutics, Inc.
1.4700
-3.92%
MLYS Mineralys Therapeutics, Inc.
14.32
-4.02%
PLRX Pliant Therapeutics, Inc.
1.3800
-6.12%
WHWK Whitehawk Therapeutics, Inc.
1.9600
-3.92%
ZURA Zura Bio Limited
1.2000
-1.64%
AVTX Avalo Therapeutics, Inc.
4.8400
-0.82%
FDMT 4D Molecular Therapeutics, Inc.
4.3900
-2.44%
THRD Third Harmonic Bio, Inc.
5.43
+0.37%